~ decisions, III.H.3, III.H.3.3
~ deposit of industrial design - priority, II.D.1.3
~ holiday - postponement of oral proceedings, III.C.4.1.3.e
~ infringement proceedings - intervention, IV.C.3.1.3
~ prior rights - novelty, I.C.1.7
Neighbouring field - inventive step, I.D.8.2
~ arguments in opposition proceedings, IV.C.1.3.4
~ arguments on appeal, IV.C.1.4.4
~ case raised by opponent in statement of grounds of appeal, IV.E.2.6.5
~ case raised by patent proprietor in statement of grounds of appeal, IV.E.2.6.5
~ documents in oral proceedings and right to be heard, III.B.2.1
New arguments, III.B.2.1.3
New claims, III.B.2.1.1
~ use of a known measure - inventive step, I.D.9.11
~ use of functional feature in a known process, I.C.6.3.1.d
Non-attendance at oral proceedings, III.B.2.3.2, III.C.3
Amended claims without amended description, III.C.3.2
Obligation to give notice, III.C.3.3
Oral proceedings, III.C.3
Right to be heard in case of ~, III.B.2.3.2
Right to be heard in case of ~, III.B.2.3
Right to present comments, III.C.3.1
Non-inventions, I.A.2
Aesthetic creations, I.A.2.3
Computer-implemented inventions, I.A.2.4
Discoveries, I.A.2.2
Mathematical methods, I.A.2.2
Methods for doing business, I.A.2.5.1
Methods for performing mental acts, I.A.2.5.2
Presentation of information - patentable inventions, I.A.2.6
Scientific theories, I.A.2.2
Word-processing, I.A.2.5.3
Non-medical use claims, I.C.6.3.2
Non-observance of time limit directly causing a loss of right, III.E.2
Definition of "time limit" in re-establishment of rights, III.E.2.1
Loss of rights and re-establishment of rights, III.E.2.4
Time limits concerning PCT and re-establishment of rights, III.E.2.3
Time limits excluded from re-establishment of rights, III.E.2.2
~ further search fees, II.B.6.1, IV.B.4.2
~ of appeal fees - appeal deemed not have been filed, IV.E.8.1.2.a
~ of claims fees, IV.B.3.7.2
~ of designation fee, IV.A.7.2
Deemed withdrawal - designation of states, IV.A.7.2.1
Non-prejudicial disclosures - novelty, I.C.1.8
Notice of appeal, IV.E.2.5.2
Notice of two months in the summons to oral proceedings, III.C.4.2
Notification, III.O
~ of loss of rights - right to a decision, III.K.1
Formalities officers, III.K.1.3
Right to a decision under Rule 112(2) EPC, III.K.1.4
~ to representatives, III.O.2
~ to third parties, III.O.3
Notoriously well known technical features, IV.B.4.1.3.a
Novelty, I.C
Amendments - ~ test, II.E.1.7.3
Ascertaining differences, I.C.4
Chemical inventions, I.C.5
Content of the relevant prior art, I.C.3
Drawings, I.C.3.6
European prior rights, I.C.1.2
Examples, I.C.3.7
National prior rights, I.C.1.7
Non-prejudicial disclosures, I.C.1.8
~ - prior use, I.C.1.9.9
Internal structure of a product and prior use, I.C.1.9.9.b
Obligation of the EPO to examine of its own motion and prior use, I.C.1.9.9.c
~ of chemical compounds, I.C.5.1
Anticipation of certain compounds, I.C.5.1.1
Novelty of enantiomers, I.C.5.1.3
Novelty of groups of substances, I.C.5.1.2
~ of therapeutic application, I.C.6.2.3
~ of use, I.C.6
First medical use, I.C.6.1
Product claim, I.C.6.1.2
Second (or further) medical use, I.C.6.2
Second (or further) non-medical use, I.C.6.3
~ test - amendments, II.E.1.7.3
PCT applications as state of the art, I.C.1.3
Proof, I.C.2
Selection inventions, I.C.5
State of the art, I.C.1
Nucleotide and amino acid sequences, II.C.6.5
Priority, II.D.2.1.10
Number of auxiliary requests, IV.E.4.4.9
Number of claims, II.A.2.3
Fees, II.A.8.1

Quick Navigation